Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks

OTTAWA – Health Canada is advising Canadians that needle-free dermal filler devices that are promoted for cosmetic skin treatments—such as reducing wrinkles and increasing lip volume—may pose health risks. These small handheld medical devices used to deposit hyaluronic acid or other dermal fillers under the skin are also known as hyaluron pens, hyapens, fog injection devices, SERA pens, and nebulizer injector guns.

Health Canada suspends Allergan’s licences for its Biocell breast implants after safety review concludes an increased risk of cancer

OTTAWA – Health Canada has completed an update to a 2017 safety review on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and has found that the rate of BIA-ALCL in Canada is significantly higher in patients with macro-textured breast implants compared to other implants. As a result, because the potential risks associated with the implants outweigh their benefits, including the rare but serious risk of BIA-ALCL, Health Canada has suspended the licences for Allergan’s Biocell breast implants (the only macro-textured implants available in Canada).